UPDATE 1-U.S. top court allows Apotex to pursue generic version of Daiichi drug

November 9, 2015 2:47 PM

15 0

WASHINGTON Nov 9 (Reuters) - The U.S. Supreme Court on Monday rejected appeals by Daiichi Sankyo Inc and Mylan Pharmaceuticals Inc seeking to stop Apotex Inc from trying to introduce a generic version of Benicar, a drug for treating hypertension.

The justices declined to review an April ruling by the U.S. Court of Appeals for the Federal Circuit in favor of Apotex.

Read more

To category page